We are live on ! Find out more
AI

AdvisorShares Investments Portfolio holdings

AUM $549M
1-Year Est. Return 32.58%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+32.58%
3 Year Est. Return
+93.4%
5 Year Est. Return
+34.9%
10 Year Est. Return
AUM
$522M
AUM Growth
-$52.5M
Cap. Flow
-$79.8M
Cap. Flow %
-15.29%
Top 10 Hldgs %
50.64%
Holding
316
New
43
Increased
78
Reduced
127
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 10.98%
2 Financials 10.03%
3 Healthcare 8.91%
4 Consumer Discretionary 8.64%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JMIA
201
Jumia Technologies
JMIA
$729M
$244K 0.05%
+45,675
New +$338K
ALKS icon
202
Alkermes
ALKS
$8.22B
$232K 0.04%
8,290
-3,100
-27% -$82.7K
TCOM icon
203
Trip.com Group
TCOM
$29.4B
$232K 0.04%
3,896
RLMD icon
204
Relmada Therapeutics
RLMD
$502M
$222K 0.04%
68,528
-21,500
-24% -$69.6K
NRXP icon
205
NRX Pharmaceuticals
NRXP
$147M
$220K 0.04%
130,085
+22,000
+20% +$44.3K
DRUG
206
Bright Minds Biosciences
DRUG
$765M
$219K 0.04%
182,420
+1,428
+0.8% +$1.61K
INCR
207
Intercure
INCR
$58.6M
$216K 0.04%
107,414
GHRS icon
208
GH Research
GHRS
$2.03B
$209K 0.04%
31,205
+8,600
+38% +$88.2K
CMND icon
209
Clearmind Medicine
CMND
$2.41M
$208K 0.04%
427
+105
+33% +$59.7K
ITCI
210
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$205K 0.04%
2,805
-900
-24% -$67.6K
NCLH icon
211
Norwegian Cruise Line
NCLH
$8.55B
$205K 0.04%
10,000
+1,000
+11% +$18.2K
VTGN icon
212
VistaGen Therapeutics
VTGN
$13M
$204K 0.04%
67,780
+16,000
+31% +$54.6K
RCL icon
213
Royal Caribbean
RCL
$82.4B
$195K 0.04%
1,100
ATAI icon
214
AtaiBeckley Inc
ATAI
$2.68B
$195K 0.04%
167,831
-33,000
-16% -$44K
ENVB icon
215
Enveric Biosciences
ENVB
$6.16M
$174K 0.03%
2,039
+278
+16% +$25.6K
INM icon
216
InMed Pharmaceuticals
INM
$7.69M
$172K 0.03%
+36,665
New +$187K
TH icon
217
Target Hospitality
TH
$1.63B
$170K 0.03%
21,889
-700
-3% -$6.54K
WH icon
218
Wyndham Hotels & Resorts
WH
$5.33B
$169K 0.03%
2,157
+500
+30% +$38K
SAGE
219
DELISTED
Sage Therapeutics
SAGE
$168K 0.03%
23,330
+7,300
+46% +$66.8K
YUMC icon
220
Yum China
YUMC
$16.4B
$167K 0.03%
+3,700
New +$123K
EXPE icon
221
Expedia Group
EXPE
$37.1B
$165K 0.03%
1,117
-400
-26% -$53K
CAKE icon
222
Cheesecake Factory
CAKE
$5.43B
$165K 0.03%
+4,058
New +$154K
INN
223
Summit Hotel Properties
INN
$671M
$164K 0.03%
+23,900
New +$152K
XHR
224
Xenia Hotels & Resorts
XHR
$1.74B
$164K 0.03%
11,080
-700
-6% -$9.72K
EAT icon
225
Brinker International
EAT
$9.71B
$156K 0.03%
2,042
-1,089
-35% -$75K

Similar funds

AdvisorShares Investments's Q3 2024 Portfolio in Review

As of Q3 2024, AdvisorShares Investments held 316 positions worth $522M, down 9.1% from $574M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

AdvisorShares Investments withdrew a net $79.8M in Q3 2024, closing 48 positions and reducing 127 holdings. Its most notable exit was iShares MSCI USA Momentum Factor ETF, an estimated $95.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

Against the trend, AdvisorShares Investments opened a new position in State Street SPDR S&P 500 ETF Trust worth $106M.

  • AdvisorShares Investments's largest Q3 2024 buy was State Street SPDR S&P 500 ETF Trust: 185,050 shares worth $106M.
  • AdvisorShares Investments added most to AdvisorShares Pure US Cannabis ETF in Q3 2024, an estimated $4.33M increase.
  • AdvisorShares Investments's biggest Q3 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $2.76M.
  • AdvisorShares Investments fully exited iShares MSCI USA Momentum Factor ETF in Q3 2024, selling an estimated $95.1M.
  • AdvisorShares Investments's ten largest holdings make up 51% of its $522M portfolio in Q3 2024.
  • AdvisorShares Investments opened 43 new positions and closed 48 in Q3 2024.
  • AdvisorShares Investments's portfolio value fell 9.1% quarter-over-quarter to $522M.

Based on AdvisorShares Investments's 13F filing for Q3 2024, filed 14 Nov 2024.